El Bouazzaoui, L.; Raats, D.A.E.; Verheem, A.; Rinkes, I.H.M.B.; Snippert, H.J.G.; Maurice, M.M.; Kranenburg, O.
Resistance to MAPK Pathway Inhibition in BRAF-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors. Organoids 2025, 4, 14.
https://doi.org/10.3390/organoids4020014
AMA Style
El Bouazzaoui L, Raats DAE, Verheem A, Rinkes IHMB, Snippert HJG, Maurice MM, Kranenburg O.
Resistance to MAPK Pathway Inhibition in BRAF-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors. Organoids. 2025; 4(2):14.
https://doi.org/10.3390/organoids4020014
Chicago/Turabian Style
El Bouazzaoui, Layla, Daniëlle A. E. Raats, André Verheem, Inne H. M. Borel Rinkes, Hugo J. G. Snippert, Madelon M. Maurice, and Onno Kranenburg.
2025. "Resistance to MAPK Pathway Inhibition in BRAF-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors" Organoids 4, no. 2: 14.
https://doi.org/10.3390/organoids4020014
APA Style
El Bouazzaoui, L., Raats, D. A. E., Verheem, A., Rinkes, I. H. M. B., Snippert, H. J. G., Maurice, M. M., & Kranenburg, O.
(2025). Resistance to MAPK Pathway Inhibition in BRAF-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors. Organoids, 4(2), 14.
https://doi.org/10.3390/organoids4020014
